Detalhe da pesquisa
1.
Clinical and serological predictors of post COVID-19 condition-findings from a Canadian prospective cohort study.
Front Public Health
; 12: 1276391, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38784593
2.
The effect of dose-interval on antibody response to mRNA COVID-19 vaccines: a prospective cohort study.
Front Immunol
; 15: 1330549, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38433831
3.
Continuous false positive results by SARS-CoV-2 rapid antigen testing: a case report.
Front Public Health
; 11: 1240308, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38026284
4.
Seasonal respiratory virus circulation was diminished during the COVID-19 pandemic.
Influenza Other Respir Viruses
; 17(1): e13065, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36369746
5.
Cross-sectional Characterization of SARS-CoV-2 Antibody Levels and Decay Rates Following Infection of Unvaccinated Elderly Individuals.
Open Forum Infect Dis
; 10(8): ofad384, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37547857
6.
Results of the Stop the Spread Ottawa (SSO) cohort study: a Canadian urban-based prospective evaluation of antibody responses and neutralisation efficiency to SARS-CoV-2 infection and vaccination.
BMJ Open
; 13(10): e077714, 2023 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37907304
7.
COVID-19 vaccine immunogenicity in people with HIV.
AIDS
; 37(1): F1-F10, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36476452
8.
Cohort profile: investigating SARS-CoV-2 infection and the health and psychosocial impact of the COVID-19 pandemic in the Canadian CHILD Cohort.
Epidemiol Health
; 45: e2023091, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37857338
9.
Antibody neutralization capacity after coronavirus disease 2019 vaccination in people with HIV in Canada.
AIDS
; 37(12): F25-F35, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37534695
10.
SARS-CoV-2 Seroprevalence in Those Utilizing Public Transportation or Working in the Transportation Industry: A Rapid Review.
Int J Environ Res Public Health
; 19(18)2022 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36141897
11.
Characterization of Systemic and Mucosal Humoral Immune Responses to an Adjuvanted Intranasal SARS-CoV-2 Protein Subunit Vaccine Candidate in Mice.
Vaccines (Basel)
; 11(1)2022 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36679875
12.
Scalable agroinfiltration-based production of SARS-CoV-2 antigens for use in diagnostic assays and subunit vaccines.
PLoS One
; 17(12): e0277668, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36516116
13.
Platelet activation by SARS-CoV-2 implicates the release of active tissue factor by infected cells.
Blood Adv
; 6(12): 3593-3605, 2022 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35443030
14.
Antibody Seronegativity in COVID-19 RT-PCR-Positive Children.
Pediatr Infect Dis J
; 41(8): e318-e320, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35544731
15.
Longitudinal profiles of plasma gelsolin, cytokines and antibody expression predict COVID-19 severity and hospitalization outcomes.
Front Immunol
; 13: 1011084, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36148234
16.
Household transmission of SARS-CoV-2 from unvaccinated asymptomatic and symptomatic household members with confirmed SARS-CoV-2 infection: an antibody-surveillance study.
CMAJ Open
; 10(2): E357-E366, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35414597
17.
Homogeneous surrogate virus neutralization assay to rapidly assess neutralization activity of anti-SARS-CoV-2 antibodies.
Nat Commun
; 13(1): 3716, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35778399
18.
Comparative performance data for multiplex SARS-CoV-2 serological assays from a large panel of dried blood spot specimens.
Heliyon
; 8(9): e10270, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36060461
19.
Prevalence of SARS-CoV-2 infection among obstetric patients in Ottawa, Canada: a descriptive study.
CMAJ Open
; 10(3): E643-E651, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35820683
20.
Cohort profile: Stop the Spread Ottawa (SSO)-a community-based prospective cohort study on antibody responses, antibody neutralisation efficiency and cellular immunity to SARS-CoV-2 infection and vaccination.
BMJ Open
; 12(9): e062187, 2022 09 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36691221